These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16533155)

  • 21. Current state and perspectives of 3D-QSAR.
    Akamatsu M
    Curr Top Med Chem; 2002 Dec; 2(12):1381-94. PubMed ID: 12470286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of quantitative structure--activity relationships (QSAR) in biomolecular discovery.
    Winkler DA
    Brief Bioinform; 2002 Mar; 3(1):73-86. PubMed ID: 12002226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment descriptors in structure-property modeling and virtual screening.
    Varnek A
    Methods Mol Biol; 2011; 672():213-43. PubMed ID: 20838971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery.
    Neves BJ; Braga RC; Melo-Filho CC; Moreira-Filho JT; Muratov EN; Andrade CH
    Front Pharmacol; 2018; 9():1275. PubMed ID: 30524275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for applying the quantitative structure-activity relationship paradigm.
    Esposito EX; Hopfinger AJ; Madura JD
    Methods Mol Biol; 2004; 275():131-214. PubMed ID: 15141113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing non-additivity of biological activity in a combinatorial library.
    Nanxiang G; Cho SJ; Hermsmeier M; Poss M; Shen CF
    Comb Chem High Throughput Screen; 2002 Mar; 5(2):147-54. PubMed ID: 11966423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria.
    Speck-Planche A; Cordeiro MN
    Curr Top Med Chem; 2015; 15(18):1801-13. PubMed ID: 25961517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using kernel alignment to select features of molecular descriptors in a QSAR study.
    Wong WW; Burkowski FJ
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural networks in building QSAR models.
    Baskin II; Palyulin VA; Zefirov NS
    Methods Mol Biol; 2008; 458():137-58. PubMed ID: 19065809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the reliability of a QSAR model's predictions.
    He L; Jurs PC
    J Mol Graph Model; 2005 Jun; 23(6):503-23. PubMed ID: 15896992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery.
    Pantaleao SQ; Fujii DGV; Maltarollo VG; da C Silva D; Trossini GHG; Weber KC; Scott LPB; Honorio KM
    Med Chem; 2017; 13(8):706-720. PubMed ID: 28530546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How good are ensembles in improving QSAR models? The case with eCoRIA.
    Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
    J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry.
    Pham-The H; Nam NH; Nga DV; Hai DT; Dieguez-Santana K; Marrero-Poncee Y; Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H
    Curr Top Med Chem; 2018 Feb; 17(30):3269-3288. PubMed ID: 29231145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.